Resistance a major hindrance to chemotherapy in hepatocellular carcinoma: an insight
Abstract Hepatocellular carcinoma (HCC) is one of the leading causes of cancer mortality, accounting for almost 90% of total liver cancer burden. Surgical resection followed by adjuvant and systemic chemotherapy are the most meticulously followed treatment procedures but the complex etiology and hig...
Egile Nagusiak: | K. Lohitesh, Rajdeep Chowdhury, Sudeshna Mukherjee |
---|---|
Formatua: | Artikulua |
Hizkuntza: | English |
Argitaratua: |
BMC
2018-03-01
|
Saila: | Cancer Cell International |
Gaiak: | |
Sarrera elektronikoa: | http://link.springer.com/article/10.1186/s12935-018-0538-7 |
Antzeko izenburuak
-
Noncoding RNA-mediated molecular bases of chemotherapy resistance in hepatocellular carcinoma
nork: Qikuan He, et al.
Argitaratua: (2022-08-01) -
Targeting and regulation of autophagy in hepatocellular carcinoma: revisiting the molecular interactions and mechanisms for new therapy approaches
nork: Mehrdad Hashemi, et al.
Argitaratua: (2023-02-01) -
CASK Silence Overcomes Sorafenib Resistance of Hepatocellular Carcinoma Through Activating Apoptosis and Autophagic Cell Death
nork: Bisha Ding, et al.
Argitaratua: (2021-06-01) -
XLF-mediated NHEJ activity in hepatocellular carcinoma therapy resistance
nork: Sitian Yang, et al.
Argitaratua: (2017-05-01) -
Chitopentaose inhibits hepatocellular carcinoma by inducing mitochondrial mediated apoptosis and suppressing protective autophagy
nork: Chunfeng Zhu, et al.
Argitaratua: (2021-01-01)